For many families who aspire to have healthy offspring, a family history of genetic disease often discourages them.

But with the popularization of assisted reproductive technology, Kyrgyzstan has become a new choice for many families due to its sound laws and regulations and cost-effective medical services.

So, if there is a family history of genetic disorders, can we still choose Kyrgyz assisted reproduction?

How does the Tulip International Reproductive Center help families block genetic risks through scientific means? Here is a deep analysis for you.

Q1: Does having a family history of genetics affect assisted reproduction in Kyrgyzstan?

The answer is: there will be an impact, but usually a positive one, because assisted reproductive technology is an effective way to solve this problem.

Family inherited diseases such as thalassemia, hemophilia, cystic fibrosis, etc. are usually passed on to the next generation through genes. Even if both prospective parents appear healthy, they may still be carriers of disease causing genes (recessive inheritance).

Natural conception faces a probability risk of transmitting diseases to the child (usually 25% or 50%).

In Kyrgyzstan, the legal assisted reproductive health system attaches great importance to this. Before accepting the commission, Tulip International Reproductive Center will advise prospective parents to undergo a detailed genetic evaluation. If there is a clear family history, doctors will develop a specialized in vitro fertilization (IVF) plan, combined with assisted reproductive procedures, using laboratory techniques for screening before embryo transfer. This is not only allowed, but also encouraged as a means of eugenics.

Q2: Core Technology Unveiled: How Genetic Testing "Screen" Healthy Babies?

In assisted reproductive laboratories in Kyrgyzstan, third-generation IVF technology is mainly relied upon to block genetic diseases. This technology is mainly divided into two levels:

1. Chromosome screening (PGT-A/PGS): This mainly targets abnormalities in chromosome number (such as Down syndrome). As women age, the rate of chromosomal abnormalities in eggs increases, which can easily lead to miscarriage or delayed fetal development. Through PGT-A technology, the laboratory team at Tulip International Reproductive Center can detect the integrity of 23 pairs of chromosomes in embryos, eliminate abnormal embryos, and significantly improve the success rate of pregnancy after transplantation.

2. Single gene disease diagnosis (PGT-M/PGD): This is a key technology for specific family genetic diseases. If prospective parents carry a specific disease causing gene (such as the Mediterranean anemia gene), doctors will first extract DNA samples from the parents to establish genetic markers. When the embryo develops to the blastocyst stage, a small number of cells are extracted through biopsy technology for detection, accurately identifying which embryos carry pathogenic genes and which are healthy.

Mr. and Mrs. M (pseudonym) both suffer from mild alpha thalassemia. Although asymptomatic on a daily basis, the risk of having a severe thalassemia child (Papal edema fetus) naturally born from the combination of two individuals is as high as 25%. They had experienced a natural pregnancy once, but during the mid-term prenatal examination, it was found that the fetus had edema all over the body, and they had to endure pain to induce labor.

The disheartened couple found the Tulip International Reproductive Center. The medical team has developed a pregnancy assistance program for them in Kyrgyzstan:

Assisted egg retrieval: Mrs. M completed assisted egg retrieval and obtained 12 mature eggs.

Embryo culture and screening: Six blastocysts were formed after ICSI insemination. The laboratory immediately utilized PGT-M technology for targeted genetic testing of thalassemia.

Results and Transplantation: The test results showed that 2 embryos were severely ill, 3 were carriers (healthy but carrying genes), and 1 was a completely healthy embryo.

The couple chose to transfer the completely healthy embryo into the body of a loving mother who had undergone a rigorous medical examination. Ten months later, a healthy male infant was born without carrying any genes that cause thalassemia.

Q3: How to ensure that caring mothers do not affect the genetic health of their babies?

This is a common concern for many expectant parents. Under the legal and medical framework of Kyrgyzstan, the role of assisted reproductive mothers is to provide a healthy uterine environment, rather than to provide eggs (genes).

1. Genetic isolation: The baby's genes come entirely from the intended parents (or donated sperm and eggs), and there is no blood relationship with the assisting mother. The blood of the assisting mother does not mix directly with the fetus, so it will not change the genetic material of the child.

2. Strict health background investigation: Tulip International Reproductive Center implements strict admission standards when recruiting volunteers for caring assisted reproduction. In addition to routine infectious disease screening (hepatitis B, syphilis, AIDS, etc.), family history survey and basic physical function assessment will also be carried out for volunteers. This ensures that she has a healthy maternal environment suitable for the development of the fetus, and avoids maternal health problems (such as pregnancy hypertension, diabetes) affecting the postnatal development of the fetus.

Q4: Is there any legal guarantee for genetic disease screening in Kyrgyzstan?

Kyrgyzstan is one of the few countries in the world that explicitly supports commercial assisted reproduction through legislation, and its legal environment is open to the use of eugenics and fertility technologies.

1. Clear medical informed consent: Before signing the assisted reproduction contract, Tulip International Reproductive Center will assist clients in signing a detailed medical informed consent form. For families with a history of genetic disorders, the contract will explicitly include provisions for pre implantation genetic testing (PGT) to ensure compliance with medical procedures.

2. Non controversial ownership of parental rights: According to the law, regardless of whether the assisting mother has undergone genetic related health checks, the child born belongs entirely to the entrusted parents in legal terms. This means that the healthy babies selected through genetic screening technology belong entirely to you, from a legal to a biological perspective.

3. Ethics and privacy protection: Legitimate reproductive centers will strictly protect customers' genetic privacy. The genetic testing report is only used for medical purposes (screening embryos) and will not be used for other commercial purposes, fully respecting the privacy rights of customers.

Family genetic diseases are not the end of fertility. With the mature assisted reproductive system in Kyrgyzstan and advanced genetic testing technologies such as PGT-M provided by the Tulip International Reproductive Center, we are fully capable of blocking the transmission of pathogenic genes. This is not only a responsibility to this generation, but also a precious gift of health for future babies.

For fertility consultation in Kyrgyzstan, please contact your dedicated consultant

/Fertility Consultation /

Dr.Chan

Copy and add: Tulip_EnoChan

Or long press/scan the QR code to add

Tulip International Fertility Center

Technology aids fertility, fulfilling dreams for countless families